Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mader

Showing results (161-170 of 221) with videos related to

Pageof 23
Sort By:
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 19, 2017
Thiosemicarbazone derivatives, thiazolyl hydrazones, effectively inhibit leukemic tumor cell growth: Down-regulation of ribonucleotide reductase activity and synergism with arabinofuranosylcytosineGeraldine Graser-Loescher, Agnes Schoenhuber, Caroline Ciglenec, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Solid-phase synthesis and investigation of benzofurans as selective estrogen receptor modulatorsRoger A Smith, Jinshan Chen, Mary M Mader, et al.
Cancer|December 12, 2003
Do we need HER-2/neu testing for all patients with primary breast carcinoma?Susanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Scientific Reports|October 20, 2025
Profiling extracellular vesicles from cerebrospinal fluid for classification of intradural spinal tumorsAmanda Salviano-Silva, Ines Stevic, Christian Mende, et al.
British Journal of Haematology|November 11, 1999
Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disordersG J Locker, S Kapiotis, M Veitl, et al.
Cell Death & Disease|September 22, 2019
High impact of miRNA-4521 on FOXM1 expression in medulloblastomaDaniel Senfter, Mahzeiar Samadaei, Robert M Mader, et al.
Scientific Reports|January 11, 2018
Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testingChristian Schoergenhofer, Michael Schwameis, Christa Firbas, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Negative chronotropic effects of fentanyl attenuate beneficial effects of dobutamine on oxygen metabolism: hemodynamic and pharmacokinetic interactionsG J Locker, R M Mader, B Rizovski, et al.
Oncology Reports|September 27, 2016
Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitroSilvio Holzner, Daniel Senfter, Serena Stadler, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2008
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancerRupert Bartsch, Catharina Wenzel, Simon P Gampenrieder, et al.
Pageof 23

Showing results (161-170 of 221) with videos related to

Sort By:
Pageof 23
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 19, 2017
Thiosemicarbazone derivatives, thiazolyl hydrazones, effectively inhibit leukemic tumor cell growth: Down-regulation of ribonucleotide reductase activity and synergism with arabinofuranosylcytosineGeraldine Graser-Loescher, Agnes Schoenhuber, Caroline Ciglenec, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Solid-phase synthesis and investigation of benzofurans as selective estrogen receptor modulatorsRoger A Smith, Jinshan Chen, Mary M Mader, et al.
Cancer|December 12, 2003
Do we need HER-2/neu testing for all patients with primary breast carcinoma?Susanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Scientific Reports|October 20, 2025
Profiling extracellular vesicles from cerebrospinal fluid for classification of intradural spinal tumorsAmanda Salviano-Silva, Ines Stevic, Christian Mende, et al.
British Journal of Haematology|November 11, 1999
Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disordersG J Locker, S Kapiotis, M Veitl, et al.
Cell Death & Disease|September 22, 2019
High impact of miRNA-4521 on FOXM1 expression in medulloblastomaDaniel Senfter, Mahzeiar Samadaei, Robert M Mader, et al.
Scientific Reports|January 11, 2018
Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testingChristian Schoergenhofer, Michael Schwameis, Christa Firbas, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Negative chronotropic effects of fentanyl attenuate beneficial effects of dobutamine on oxygen metabolism: hemodynamic and pharmacokinetic interactionsG J Locker, R M Mader, B Rizovski, et al.
Oncology Reports|September 27, 2016
Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitroSilvio Holzner, Daniel Senfter, Serena Stadler, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2008
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancerRupert Bartsch, Catharina Wenzel, Simon P Gampenrieder, et al.
Pageof 23